Hemant R Kanase

  • Commentry
    Pharmacovigilance Programme of India: The Beginning, Current Status and Recent Progress
    Author(s): Kritarth Naman M Singh and Hemant R KanaseKritarth Naman M Singh and Hemant R Kanase

    Pharmacovigilance is a crucial part of drug development process which helps in assessing any drug’s adverse event profile. Years after the start of WHO’s International Drug Monitoring Programme, Government of India launched the Pharmacovigilance Programme of India (PvPI) in 2010. The main function of PvPI is monitoring the Adverse Drug Reactions (ADR) efficiently by setting up various Adverse Drug Reaction Monitoring Centres (AMC) across India and training personnel who can perform this function. PvPI has played an important role in generating awareness amongst healthcare professionals (HCPs) about the importance and the process of reporting ADRs which has led to a multifold increase in ADR reporting. There have been recent developments and advancements overseen by PvPI with a view to further increase the reach of pharmacovigilance across the country, which would further r.. View More»
    DOI: 10.4172/2167-1052.1000219

    Abstract PDF